دورية أكاديمية
NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route
| العنوان: | NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route |
|---|---|
| المؤلفون: | Amissah, Obed BoadiAff1, Aff2, Aff3, IDs1293502403249w_cor1, Chen, WenfangAff1, Aff2, de Dieu Habimana, Jean, Sun, Yirong, Lin, Lihui, Liu, Yujie, Wang, LingAff1, Aff4, Liu, ZhaomingAff1, Aff2, Mukama, Omar, Basnet, RajeshAff1, Aff2, Liu, Hohua, Li, JunyiAff1, Aff2, Ding, XuanyanAff1, Aff2, Lv, LingshuangAff1, Aff2, Chen, MinAff1, Aff4, Liang, Yalin, Huang, RongqiAff1, Aff3, IDs1293502403249w_cor17, Li, ZhiyuanAff1, Aff2, Aff3, Aff4, Aff6, Aff7, IDs1293502403249w_cor18 |
| المصدر: | Cancer Cell International. 24(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 14752867 |
|---|---|
| DOI: | 10.1186/s12935-024-03249-w |